Filtered By:
Specialty: Health Management
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 916 results found since Jan 2013.
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
ConclusionsHCRU and most event-related costs were lower in patients initiating apixaban compared to other OACs. Apixaban may be cost-saving compared to VKAs, and significantly cheaper than other DOACs, although cost differences are limited.
Source: The European Journal of Health Economics - August 28, 2022 Category: Health Management Source Type: research
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis
CONCLUSION: Adherence improving interventions for NVAF patients on DOACs such as chronic disease co-management and patient education can be cost-saving and cost-effective, within a range of costs that appear reasonable to the Swedish healthcare system.PMID:35997241 | DOI:10.1080/13696998.2022.2116848
Source: Journal of Medical Economics - August 23, 2022 Category: Health Management Authors: C Blomstr öm Lundqvist S Sj älander L A Garcia Rodriguez Ö Åkerborg G Jin A Caleyachetty M Huelsebeck K Bowrin B Schaefer H Mahdessian L Hofmeister L Å Levin Source Type: research
Evaluating the cost-utility of a direct transfer to angiosuite protocol within 6 hours of symptom onset in suspected large vessel occlusion patients
CONCLUSIONS: Our economic model predicts that the implementation of a DTAS program is cost-effective compared to no organizational changes. Our model also predicts better clinical outcomes for patients in terms of functional independence and quality-adjusted life years.PMID:35960180 | DOI:10.1080/13696998.2022.2113221
Source: Journal of Medical Economics - August 12, 2022 Category: Health Management Authors: Manuel Requena Valeska Seguel Andreu Vilaseca-Jolonch Jacklyn Woods Pablo Guijarro Marc Ribo Alejandro Tomasello Carlos A Molina Source Type: research
Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries
ConclusionsDescriptive results were the main driver of 3L –5L responsiveness differences. Responsiveness of 3L was influenced by the ‘confined to bed’ label and the overestimation bias of 3L, which affected all responsiveness results. This may impact quality-adjusted life-year (QALY) estimations, leading to over- or underestimations of QALYs gained, depending on the condition and condition severity. QALY calculations based on 5L data will result in more accurate estimates.
Source: PharmacoEconomics - August 5, 2022 Category: Health Management Source Type: research
A workplace strategy to protect against strokes won ’t just help strengthen your business — it may also help save a life
According to the Centers for Disease Control, someone in the United States suffers a stroke every 40 seconds. And, every 3.5 minutes, someone dies from one. In fact, 1 in every 6 deaths from cardiovascular issues is due to stroke, making them the 4th leading killer across the country.
The economic toll on businesses is just as sobering: Each year, stroke-related health care services, medicine, and missed days of work add up to $53 billion nationwide. Combine stroke costs to expenses from other …
Source: bizjournals.com Health Care News Headlines - August 1, 2022 Category: Health Management Authors: Dr. Keith H. Bachman Source Type: news
